UCLA CTSI is broadening LA County collaborations and expanding initiatives with renewed CTSA funding

The UCLA CTSI is a research partnership of the University of California Los Angeles, Charles R. Drew University of Medicine and Science, Cedars-Sinai Medical Center, and Harbor-UCLA Medical Center/Lundquist Institute for Biomedical Innovation. The UCLA CTSI is expanding its efforts to translate discoveries that can improve the health of Los Angeles County’s diverse population. This is facilitated by the renewal of a Clinical and Translational Science Award from the National Center for Advancing Translational Science in the National Institutes of Health.

Over the next five years, the UCLA CTSI will build on its progress by broadening collaborations with the Los Angeles community as well as with faculty across a wide area of expertise, including the schools of medicine, engineering, business, education and public health. The CTSI also plans to establish mobile units to bring clinical trials to underserved communities; enhance training and education programs with team science principles; and apply its expertise in data science and artificial intelligence to improve health care delivery. The UCLA CTSI has embarked on an Inclusive Science Initiative that supports diversity, equity and inclusion in all research activities as well as in research training.

CTSA Program In Action Goals
Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan